Table 4.
Population (n, case/control) | Phwe | Risk Allele | Frequency (Case/Control) |
Before adjustment | After adjustment | ||
---|---|---|---|---|---|---|---|
| |||||||
Pobsa | OR(95%CI) | Padjb | OR(95%CI) | ||||
Overall CAD (4,479/3,628) | 0.08 | G | 0.34/0.33 | 0.08 | 1.06 (0.99–1.14) | 0.08 | 1.07 (0.99–1.15) |
Early-onset CAD (1,541/3,628) | 0.08 | G | 0.33/0.33 | 0.94 | 1.00 (0.89–1.14) | 0.64 | 1.04 (0.89–1.20) |
Female CAD (1,698/1,329) | 0.33 | G | 0.35/0.33 | 0.51 | 1.04 (0.93–1.16) | 0.62 | 1.03 (0.91–1.16) |
Male CAD (2,707/2,242) | 0.20 | G | 0.33/0.32 | 0.05 | 1.09 (1.00–1.19) | 0.07 | 1.09 (0.99–1.19) |
Phwe, P value from Hardy-Weinberg disequilibrium tests; Pobs, observed P value; Padj, P value after adjustment for covariates of age and gender; OR, odds ratio; 95% CI, 95% confidence interval; Early-onset CAD, males age 50 years or younger; females age 55 years or younger at the first diagnosis of the disease.